Evidence map›Paper›PMID 27134158›Full record

ReviewInternational journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases2016

Management of infections in critically ill returning travellers in the intensive care unit-I: considerations on infection control and transmission of resistance.

Hakan Leblebicioglu, Alfonso J Rodriguez-Morales, Gian Maria Rossolini, Rogelio López-Vélez, Jean-Ralph Zahar, Jordi Rello, ESGCIP and ESGITM

Open access · goldAbstract readReview
In one paragraph

Review in International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 28 citations in OpenAlex.

  1. Pooled it
  2. The Emergence of Travel-related Infections in Critical Care Units.Journal of translational internal medicine · 2022
    Article
  3. Fever in the Returning Traveler.Deutsches Arzteblatt international · 2022
    Review
  4. Article
  5. Critical illness in the returning traveller.Journal of the Intensive Care Society · 2022
    Article
  6. Article
  7. Emergency management to avoid the spread of the COVID-19 pandemic in Gaza Strip.The International journal of health planning and management · 2021
    Article
  8. Clinical Microbiology in the Intensive Care Unit: Time for Intensivists to Rejuvenate this Lost Art.Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine · 2021
    Review
  9. Article
  10. FMC : Formacion medica continuada en atencion primaria · 2020
    Article
  11. Article
  12. Review
  13. Article
  14. Importance of a Travel History in Evaluation of Respiratory Infections.Current emergency and hospital medicine reports · 2016
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 5 countries.

Hakan LeblebiciogluDepartment of Infectious Diseases and Clinical Microbiology, Ondokuz Mayis University Medical School, Samsun, Turkey.
Alfonso J Rodriguez-MoralesPublic Health and Infection Research Group, Faculty of Health Sciences, Universidad Tecnológica de Pereira, Pereira, Risaralda, Colombia.
Gian Maria RossoliniDepartment of Medical Biotechnologies, University of Siena, Siena, Italy; Department of Experimental and Clinical Medicine, University of Florence, and Clinical Microbiology and Virology Unit, Florence Careggi University Hospital, Florence, Italy.
Rogelio López-VélezNational Referral Unit for Tropical Diseases, Infectious Diseases Department, Ramón y Cajal University Hospital, Madrid, Spain.
Jean-Ralph ZaharInfection Control Unit, Université d'Angers, Centre Hospitalier Universitaire d'Angers, Angers, France.
Jordi RelloCIBERES, Vall Hebron Research Institute, Universitat Autònoma de Barcelona, Barcelona, Spain. Electronic address: jrello@crips.es.
ESGCIP and ESGITM
Ondokuz Mayıs University · TRTechnological University of Pereira · COUniversitat Autònoma de Barcelona · ESUniversité d'Angers · FRUniversity of Florence · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Depending on their destinations and activities, international travellers are at a significant risk of contracting both communicable and non-communicable diseases. On return to their home countries, such travellers may require intensive care. The emergence of severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV), and more recently Ebola haemorrhagic fever, has highlighted the risks. Other well-known communicable pathogens such as methicillin-resistant Staphylococcus aureus and carbapenemase-producing Enterobacteriaceae have been described previously. However, malaria remains by far the most important cause of death. The issues related to imported antibiotic resistance and protection from highly contagious diseases are reviewed here. Surveillance strategies based on epidemiological data (country visited, duration of travel, and time elapsed since return) and clinical syndromes, together with systematic search policies, are usually mandatory to limit the risk of an outbreak. Single-bed hospital rooms and isolation according to symptoms should be the rule while awaiting laboratory test results. Because person-to-person contact is the main route of transmission, healthcare workers should implement specific prevention strategies.

Indexed as

Critical IllnessIntensive Care UnitsTravelDisease OutbreaksHumansInfection ControlInfectionsICUInfection controlMigrantResistanceTraveller

Identifiers

PMID27134158
PMCPMC7110831
OpenAlexW2342868073

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.